# Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

> **NCT03667053** · PHASE3 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 42 (actual)

## Conditions studied

- Hypoglycemia

## Interventions

- **DRUG:** dasiglucagon
- **DRUG:** placebo
- **DRUG:** GlucaGen HypoKit

## Key facts

- **NCT ID:** NCT03667053
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-28
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03667053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03667053, "Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03667053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*